Since 2013, there has been a noticeable increase in the information provided by the Food and Drug Administration (FDA) on the effects of prescription and over-the-counter medication on driving, such as allergy medications and sleep drugs. More and more, the FDA demands that certain drugs be tested for impaired effects and, given the long lead time on such studies, sponsors may not know of the requirement until the final stages of drug development.
Algorithme Pharma and Cognitive Research Corporation (CRC) have partnered to provide sponsors with a state-of-the-art driving simulator study solution to test the impaired effects of a wide variety of drugs on driving abilities in both normal and patient populations. The simulator provides accurate driving performance data comparable in sensitivity to over-the-road-testing — in less time, for less money, and without the crashes. The customized driving simulator can also be used to evaluate the effects of age, trauma, neurologic disease, alcohol and fatigue on driving performance.
Thanks to the extensive training provided by CRC, Algorithme Pharma now has fully-certified driving simulator study specialists on site.